JFS WEALTH ADVISORS, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$14,929
-1.5%
9650.0%0.00%0.0%
Q2 2023$15,161
-24.5%
965
-20.8%
0.00%
-50.0%
Q1 2023$20,090
-8.1%
1,219
-13.1%
0.00%0.0%
Q4 2022$21,871
-83.9%
1,402
-86.6%
0.00%
-86.7%
Q3 2022$136,000
-6.2%
10,448
+1.4%
0.02%0.0%
Q2 2022$145,000
-6.5%
10,303
-4.8%
0.02%0.0%
Q1 2022$155,000
-6.6%
10,824
-11.2%
0.02%
-6.2%
Q4 2021$166,000
-8.3%
12,186
+10.2%
0.02%
-15.8%
Q3 2021$181,000
-2.7%
11,0550.0%0.02%
-32.1%
Q2 2021$186,000
+10.7%
11,055
+20.0%
0.03%
-17.6%
Q1 2021$168,000
+9.1%
9,210
+9.1%
0.03%
+6.2%
Q4 2020$154,000
+13.2%
8,439
+10.7%
0.03%0.0%
Q3 2020$136,000
+8.8%
7,621
+8.9%
0.03%0.0%
Q2 2020$125,000
+23.8%
6,998
+5.5%
0.03%
+6.7%
Q1 2020$101,000
-1.0%
6,635
+28.1%
0.03%
+20.0%
Q4 2019$102,000
+14.6%
5,1790.0%0.02%
+8.7%
Q3 2019$89,000
+74.5%
5,179
+78.7%
0.02%
+76.9%
Q2 2019$51,000
-13.6%
2,8980.0%0.01%
-13.3%
Q1 2019$59,000
+37.2%
2,898
+13.6%
0.02%
+25.0%
Q4 2018$43,0002,5520.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders